Showing results (501-510 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|July 18, 2015
New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic reviewEline E B De Clerck, Jan S A G Schouten, Tos T J M Berendschot, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2015
New forms of insulin and insulin therapies for the treatment of type 2 diabetesAvivit Cahn, Roberto Miccoli, Angela Dardano, et al.
The Lancet. Diabetes & Endocrinology|May 17, 2015
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trialSayeed Ikramuddin, Charles J Billington, Wei-Jei Lee, et al.
The Lancet. Diabetes & Endocrinology|August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialYang He, Nianrong Mi, Zhifeng Cheng, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Maternal obesity and risk of cardiovascular diseases in offspring: a population-based cohort and sibling-controlled studyNeda Razaz, Eduardo Villamor, Giulia M Muraca, et al.
The Lancet. Diabetes & Endocrinology|October 23, 2019
Diabetes: a metabolic and reproductive disorder in womenEleanor P Thong, Ethel Codner, Joop S E Laven, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2020
Practical recommendations for the management of diabetes in patients with COVID-19Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2021
Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupJenneke E van Atteveld, Renée L Mulder, Marry M van den Heuvel-Eibrink, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2023
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trialMargaretha M Visser, Sara Charleer, Steffen Fieuws, et al.
The Lancet. Diabetes & Endocrinology|November 13, 2016
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trialHood Thabit, Sara Hartnell, Janet M Allen, et al.
Pageof 93